Tech Company Financing Transactions

Agensys Funding Round

Alta Partners, Bear Stearns Health Innoventures and OrbiMed joined a $42.8 million funding round for Agensys. The round was recorded on 3/5/2002.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

1545 17th St.
Santa Monica, CA 90404
USA

Phone

(310) 820-8029

Website

www.agensys.com

Email Address

[email protected]

Overview

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Donald Rice

        

Chief Financial Officer

Paul Kanan

        

Chief Scientific Officer

Aya Jakobovits

        

VP - Bus. Development

Christopher Morl

        

Browse more venture capital transactions:

Prev: 2/20/2002: ViaTRON Systems venture capital transaction
Next: 8/20/2002: Dune Networks venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary